Monthly Archives: April 2013

HVTN 505 Investigator: “We’ve got to keep moving the stone up the hill”

By on .

A week to the day after a monitoring board told organizers of the clinical vaccine research trial known as HVTN 505 to stop inoculating participants, only a few certainties have surfaced. One is that the would be vaccine regimen did not prevent HIV infections. The other is that the search for an effective vaccine will […]

While role stretches from “dignified care for the dying” to tackling gender inequities, compensation for community care-givers remains a challenge

By on .

In countries where populations live scattered, separated by long distances from understaffed clinics and hospitals, the answers to the HIV epidemic — care, treatment, prevention — rested on the shoulders of community health workers from the start. As donors and governments recognized the needs HIV spelled out for comprehensive services — for food and nutrition, […]

Disappointing vaccine trial news, key populations, PEPFAR blueprint all part of Jhpiego’s “The Present and the Future of HIV Prevention”

By on .

A chart of clinical research trials seeking ways to control HIV transmission makes for an impressive display of tenacity, with interrupted trials, ongoing trials, trials that led to other trials, and new trials in their earliest stages. It includes trials of microbicides, vaccines, antiretroviral-drug-based approaches and all of that in different combinations. It includes heartening […]

Bill would acknowledge, sustain USAID role in global health research and development

By on .

At a time when global health responses are threatened by budget-cutting fever, a “deficit neutral” bill proposed by Rep. Albio Sires (D-NJ), and Rep. Mario Diaz-Balart (R-FL) would create a comprehensive strategy to get the most out of a government investment with some of the biggest returns: global health research and development. The 21rst Century […]

The cost of cutting PEPFAR, What VOICE did tell us, and answers to other pressing questions . . .

By on .

If we want an AIDS-free generation, why are we cutting PEPFAR? The Obama administration’s budget request for fiscal year 2014, which includes a fourth consecutive cut to funding for the President’s Emergency Plan For AIDS Relief that would bring the program to its lowest funding level since 2007, raises questions, this piece by amfAR public […]

Guns, apartheid, recycling . . . all part of oral arguments as Supreme Court takes on “anti-prostitution pledge”

By on .

What if the government was awarding a contract to fight malaria in a developing country, and an organization bidding for the work had all the technical expertise the work called for, but also a history of criticizing the government? Should that keep the organization from getting the contract? Could one of the strings attached to […]

How the Medicines Patent Pool expands access to live-saving HIV treatment

By on .

At last week’s Global Aids Policy Partnership meeting, representatives from the Medicines Patent Pool gave a presentation on their organization, which works to expand access to life-saving antiretroviral (ARV) medicines in the developing world by working with patent holders to negotiate licenses for key HIV medicines patents.  This allows generic drug companies to produce high […]

Reports: Sexual minorities, youth, left out countries’ decisions on distribution of Global Fund money

By on .

The recent arrest of Zambian HIV treatment and human rights advocate Paul Kasonkomona for only talking about legal barriers to HIV and other health services for Zambians who are prisoners, sex workers or members of sexual minorities, raises the question of how those barriers can be addressed by the country’s board charged with distributing money […]

IDUs need better treatment and care in What We’re Reading

By on .

Factors associated with mortality of HIV-positive clients receiving methadone maintenance treatment in China:  Increasing daily methadone doses for Chinese injection drug users (IDUs) receiving methadone maintenance treatment reduces mortality in both HIV-infected and uninfected individuals, according to a study recently published in the Journal or Infectious Diseases.  Enwu Liu and other researchers examined records of […]

Report from Maputo: Snapshots of TB/HIV efforts in Zambia, Zimbabwe

By on .

Zambia:  TB Control Pilot generates recommendations In 2010 a Human Rights Watch report charged the Zambian prison system with severe overcrowding, gross human rights violations and conditions that perpetuate infectious diseases, notably tuberculosis. The report led to a partnership between the Centre for Infectious Disease Research in Zambia with funding from the President’s Emergency Plan […]